MRC1 and breast cancer: A recent sequencing study has reported pathogenic variants in 12 BC predisposition genes in 22.3% of 224 Kazakh patients selected for early‐onset BC,30 while neither MMR gene variants nor EC cases have been assessed in this population, to our best knowledge.